News

Edelson Lechtzin LLP Investigates Simulations Plus for Misconduct

Edelson Lechtzin LLP Investigates Simulations Plus for Misconduct

Edelson Lechtzin LLP Investigates Simulations Plus

Edelson Lechtzin LLP is taking serious steps to investigate potential breaches of federal securities laws by Simulations Plus, Inc. (NASDAQ: SLP). Allegations have surfaced indicating that Simulations Plus may have provided misleading information to its investors, which has raised significant concerns.

Understanding the Allegations Against Simulations Plus

The investigation centers on claims that Simulations Plus misled the public regarding its business operations. This situation has recently come to light, with various investors expressing concerns over substantial losses. The firm is particularly focused on gathering any information that could assist in shedding light on these claims.

The Impact of Auditing Decisions

In mid-2025, Simulations Plus hired Grant Thornton as its auditor. Following the release of weak Q3 preliminary results in June, citing unpredictability in the market, the company's stock experienced a sharp decline, losing over 24% of its value, settling at $20.05 per share.

In July, the situation worsened when Simulations Plus announced a staggering $77.2 million charge that was linked to previous acquisitions. The dismissal of Grant Thornton, following unresolved concerns related to reporting and internal control issues, led to a further drop of 25.76%, lowering the stock price to $12.97.

What Should Investors Do?

If you are an investor affected by these events or have insights that might aid the investigation, it’s important to reach out. Edelson Lechtzin LLP encourages investors who have faced losses to get in touch. Not only will you find out more about your options, but you may also assist in the broader investigation.

About Simulations Plus

Simulations Plus specializes in delivering software and expert consulting services aimed primarily at the pharmaceutical industry. Their innovative solutions are designed to enhance drug discovery and development processes, ensuring efficacy and safety in new drug formulations.

About Edelson Lechtzin LLP

Edelson Lechtzin LLP is a leading law firm with a national presence, operating offices in both Pennsylvania and California. The firm's expertise extends to class action litigation involving securities fraud, investment disputes, and other significant legal matters. Their commitment to advocating for investors and holding companies accountable is a cornerstone of their practice.

For any assistance or inquiries related to the investigation, you can reach out to attorneys Eric Lechtzin or Marc Edelson by calling 844-563-5550. They will provide you with the necessary information and guidance through this process.

Frequently Asked Questions

What should I do if I've lost money investing in Simulations Plus?

If you're an investor who has experienced losses, consider contacting Edelson Lechtzin LLP to find out how you can participate in the investigation and explore your options.

Is there an ongoing investigation against Simulations Plus?

Yes, Edelson Lechtzin LLP is currently investigating potential securities law violations involving Simulations Plus.

How has the stock price of Simulations Plus been impacted?

After reporting lackluster results and parting ways with their auditor Grant Thornton, the stock price of Simulations Plus significantly dropped, reflecting investor concerns.

What is the role of Edelson Lechtzin LLP in this case?

The firm is leading the investigation into the allegations against Simulations Plus, helping affected investors and seeking to hold the company accountable for any wrongdoing.

Can I still invest in Simulations Plus while the investigation is ongoing?

Yes, you can still invest, but it's crucial to stay informed about the developments of the investigation and its potential impacts on the company's future.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Onodrim Raises $300M to Propel EU Defence Future

Updated Category News Views 182

Onodrim Industries' Bold Bid to Reshape European Security Right out of the gate, Onodrim Industries is thundering onto the scene with a hefty $300 million Series A round to flex its muscles across Europe's defence and industrial sectors. This ain't your run-of-the-mill startup story. This is about flexing hard-earned capital to snap up established players and inject a...

Continue Reading
Election Fallout: Middle-Class Split Persists Despite Votes

Updated Category News Views 7

The Unseen Election Loser: Middle-Class Unity Seems like every four years, Americans shuffle the seats of power, but Paul Eckert believes the real problem isn't chairs changing; it's the folks sitting in them. With his book, "Healing Middle-Class Democracy," Eckert tackles a split as old as time—or at least since the '80s: the fracture within the middle class....

Continue Reading
AI Faces Accountability Trials in Business 2027

Updated Category News Views 71

Charting the AI Accountability Course In 2027, the corporate AI landscape won't be the Wild West anymore; it's morphing into a structured battlefield where the winners will be those who successfully enforce accountability. The hands-off, carte blanche days of AI are fading fast, and businesses are starting to scrutinize the AI tools they've been throwing money at. "The...

Continue Reading
Why Retaining Wall Drainage Can’t Be an Afterthought

Updated Category News Views 47

The overlooked hero in wall longevity People might think building a retaining wall is just stacking stones or pouring concrete, but that's only part of the story. According to Justin Hundich, our go-to guy on landscape and drainage matters, there's way more at play than meets the eye. If you ignore drainage, you're steaming toward disaster, my friend—no two ways about...

Continue Reading
Coframe Nets $35M for AI-Driven 'Living Internet'

Updated Category News Views 23

Transforming Digital Experiences with AI If you're tired of seeing the same dull homepage every time you visit a website, Coframe's got news for you. This startup scored a hefty $35 million to fund its vision—a 'Living Internet' that learns and adapts to each visitor. Khosla Ventures and Hanabi Capital are banking on this runaway train—that's commitment to tech...

Continue Reading
Ericsson Buybacks: Strategic Moves or Market Maneuver?

Updated Category News Views 90

Breaking Down Ericsson's Strategic Share Buybacks When a company like Ericsson starts pulling stocks off the shelves like they're on sale, it's time to take notice. Between November 2nd and 6th, Ericsson, that telecom giant we all know, went on a little shopping spree, snapping up 500,000 of its own Class B shares. Why should we care? Well, it's a part of their hefty SEK...

Continue Reading
SOTERIA and Tempus Unite for Military Cancer Battle

Updated Category News Views 17

The Military Faces Cancer's Grasp: A New Frontline There's a battle brewing in the healthcare world, one distinctly different from the chaos of stock tickers or quarterly earnings. It's about saving lives in a space where tactical precision is everything—cancer care for U.S. military personnel and veterans. SOTERIA Precision Medicine Foundation and Tempus (NASDAQ: TEM)...

Continue Reading
Summit Midstream's Q3 Financial Results Signal Growth

Updated Category News Views 14

Summit Midstream Delivers Strong Q3 Results Good grief, you'd think the grease is sliding off the griddle with these numbers. Summit Midstream Corporation (NYSE:SMC) is putting up figures that ought to make even the most poker-faced of traders crack a smile. We've got a net income sitting pretty at $15.9 million, and an Adjusted EBITDA that's climbed up to $70.7 million....

Continue Reading
Ritz-Carlton Yacht Collection Sets Sail with New Leaders

Updated Category News Views 137

Charting New Waters in Luxury Cruising Change is cruising on the open sea, folks—captained by Alan Leibman and Tatiana Ferreira, who're now at the helm of The Ritz-Carlton Yacht Collection. These names aren't just flotsam in the breeze; they're packing as much pedigree as you'd find in a top-shelf bottle of Champagne. They aren't steering yachts for a joyride; the...

Continue Reading
TalentNeuron and CodeSignal Team Up: Impact on Workforce

Updated Category News Views 83

Skills Intelligence Takes Center Stage There's a fresh breeze blowing through the workforce planning domain, thanks to the newly expanded partnership between TalentNeuron and CodeSignal. They've strapped together their expertise to craft what's now touted as the most comprehensive skills intelligence available to organizations. A claim big enough to make us stop,...

Continue Reading

Top 5 Most Recently Viewed Articles

Harvard Bioscience Unveils Advanced Solutions at SOT Meeting

Updated Category News Views 258

Harvard Bioscience Showcases Innovations at SOT Harvard Bioscience, Inc. (NASDAQ: HBIO) has announced the exciting unveiling of its cutting-edge product innovations during the Society of Toxicology (SOT) conference. This prestigious event spans several days, allowing industry leaders to explore advancements that have the potential to revolutionize preclinical research and...

Continue Reading
NorthWestern Energy Collaborates on Major Grid Expansion Projects

Updated Category News Views 350

NorthWestern Energy's Commitment to Grid Enhancement NorthWestern Energy Group, Inc., commonly known as NorthWestern Energy (NASDAQ: NWE), is taking significant strides to enhance Montana's power grid. By participating in new high-voltage transmission projects, the company aims to address the growing energy demands in the state and improve energy security for its...

Continue Reading
United Real Estate Ranks #1 Among U.S. Brokerages by Revenue

Updated Category News Views 80

United Real Estate Sets the Standard for Growth United Real Estate continues to impress the industry by establishing itself as the fastest-growing national brokerage based on revenue. This accomplishment underscores the company's ability to adapt to a changing market while staying committed to providing exceptional opportunities for its agents. Key Achievements and...

Continue Reading
Abercrombie & Fitch's Recent Surge: A Retail Investment Insight

Updated Category News Views 189

Why Abercrombie & Fitch Is Gaining Traction Are you considering adding a value stock to your portfolio? Look no further than Abercrombie & Fitch, which has recently shown impressive performance in the stock market. Despite a tough year facing challenges in the retail sector, Abercrombie & Fitch (NYSE: ANF) saw a jump in its share price, gaining about 5% on a recent...

Continue Reading
Axcellant Launches Innovative Clinical Trial in Nuclear Medicine

Updated Category News Views 214

Axcellant Launches Innovative Clinical Trial Initiative Axcellant, a European Clinical Research Organization (CRO), has announced an exciting new clinical trial that focuses on nuclear medicine. This groundbreaking study aims to greatly improve diagnostic pathways, potentially benefiting over 20 million patients in the United States and more than 200 million worldwide....

Continue Reading